Pricing
Login
Home
Charts
Search
Watchlist
Products

Haleos Labs Limited

HALEOSLABS
₹1,610.80+1.92%20 Nov 2026
Reports
Pharma API

Haleos Labs Limited

HALEOSLABS
₹1,610.80
+1.92%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹487Cr
Close
Close Price
₹1,610.80
Industry
Industry
Pharma API
PE
Price To Earnings
37.59
PS
Price To Sales
1.46
Revenue
Revenue
₹334Cr
Rev Gr TTM
Revenue Growth TTM
-0.99%
PAT Gr TTM
PAT Growth TTM
-44.67%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
729093788589838195757391
Growth YoY
Revenue Growth YoY%
-18.441.224.013.317.4-1.0-10.93.712.0-15.7-11.612.3
Expenses
ExpensesCr
637976707282716881716483
Operating Profit
Operating ProfitCr
911169137121414498
OPM
OPM%
12.912.617.610.915.18.314.216.714.85.512.59.1
Other Income
Other IncomeCr
120202100200
Interest Expense
Interest ExpenseCr
232222222122
Depreciation
DepreciationCr
444444444444
PBT
PBTCr
4711574789132
Tax
TaxCr
014120322120
PAT
PATCr
467353467022
Growth YoY
PAT Growth YoY%
7.8206.6285.4850.017.7-46.2-38.394.837.1-90.2-58.0-72.6
NPM
NPM%
5.77.27.74.25.73.95.37.97.00.52.51.9
EPS
EPS₹
14.219.523.115.518.19.813.820.221.91.48.810.8
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
729093788589838195757391
Growth YoY
Revenue Growth YoY%
-18.441.224.013.317.4-1.0-10.93.712.0-15.7-11.612.3
Expenses
ExpensesCr
637976707282716881716483
Operating Profit
Operating ProfitCr
911169137121414498
OPM
OPM%
12.912.617.610.915.18.314.216.714.85.512.59.1
Other Income
Other IncomeCr
120202100200
Interest Expense
Interest ExpenseCr
232222222122
Depreciation
DepreciationCr
444444444444
PBT
PBTCr
4711574789132
Tax
TaxCr
014120322120
PAT
PATCr
467353467022
Growth YoY
PAT Growth YoY%
7.8206.6285.4850.017.7-46.2-38.394.837.1-90.2-58.0-72.6
NPM
NPM%
5.77.27.74.25.73.95.37.97.00.52.51.9
EPS
EPS₹
14.219.523.115.518.19.813.820.221.91.48.810.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
378261266350316306345334334
Growth
Revenue Growth%
-31.01.831.8-9.9-3.012.7-3.2-1.0
Expenses
ExpensesCr
343235235316287275300289299
Operating Profit
Operating ProfitCr
352530342931454536
OPM
OPM%
9.29.711.49.89.110.213.113.410.7
Other Income
Other IncomeCr
3221454523
Interest Expense
Interest ExpenseCr
6556710967
Depreciation
DepreciationCr
688101115151516
PBT
PBTCr
251520331710262515
Tax
TaxCr
846754775
PAT
PATCr
18101425116191811
Growth
PAT Growth%
-42.933.186.6-55.0-44.4196.0-5.0-44.7
NPM
NPM%
4.73.95.17.23.62.15.45.33.2
EPS
EPS₹
59.033.744.883.637.930.166.557.342.9
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
378261266350316306345334334
Growth
Revenue Growth%
-31.01.831.8-9.9-3.012.7-3.2-1.0
Expenses
ExpensesCr
343235235316287275300289299
Operating Profit
Operating ProfitCr
352530342931454536
OPM
OPM%
9.29.711.49.89.110.213.113.410.7
Other Income
Other IncomeCr
3221454523
Interest Expense
Interest ExpenseCr
6556710967
Depreciation
DepreciationCr
688101115151516
PBT
PBTCr
251520331710262515
Tax
TaxCr
846754775
PAT
PATCr
18101425116191811
Growth
PAT Growth%
-42.933.186.6-55.0-44.4196.0-5.0-44.7
NPM
NPM%
4.73.95.17.23.62.15.45.33.2
EPS
EPS₹
59.033.744.883.637.930.166.557.342.9
Sales CAGR
1 Year-3%
3 Years2%
5 Years5%
TTM-1%
EBITDA CAGR
1 Year-1%
3 Years16%
5 Years8%
TTM-22%
PAT CAGR
1 Year-5%
3 Years16%
5 Years6%
TTM-45%
Avg. ROCE
1 Year10%
3 Years10%
5 Years11%
TTM6%
CFO / EBITDA
1 Year83%
3 Years79%
5 Years54%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
333333333
Reserves
ReservesCr
103113126149166174194211216
Current Liabilities
Current LiabilitiesCr
12587114135134145142156189
Non Current Liabilities
Non Current LiabilitiesCr
395059567352366978
Total Liabilities
Total LiabilitiesCr
270253302357395391390454500
Current Assets
Current AssetsCr
142107126156159156151163199
Non Current Assets
Non Current AssetsCr
128146176201236235239291300
Total Assets
Total AssetsCr
270253302357395391390454500
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
333333333
Reserves
ReservesCr
103113126149166174194211216
Current Liabilities
Current LiabilitiesCr
12587114135134145142156189
Non Current Liabilities
Non Current LiabilitiesCr
395059567352366978
Total Liabilities
Total LiabilitiesCr
270253302357395391390454500
Current Assets
Current AssetsCr
142107126156159156151163199
Non Current Assets
Non Current AssetsCr
128146176201236235239291300
Total Assets
Total AssetsCr
270253302357395391390454500

Cash Flow

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
301535-1115243437
Investing Cash Flow
Investing Cash FlowCr
-44-27-26-7-31-18-15-58
Financing Cash Flow
Financing Cash FlowCr
1512-31117-7-1921
Net Cash Flow
Net Cash FlowCr
106-80-101
Free Cash Flow
Free Cash FlowCr
6-90-53-28419-21
CFO To PAT
CFO To PAT%
168.1142.8259.4-44.4129.2384.1181.8209.1
CFO To EBITDA
CFO To EBITDA%
86.457.3116.5-32.651.178.175.683.3
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
301535-1115243437
Investing Cash Flow
Investing Cash FlowCr
-44-27-26-7-31-18-15-58
Financing Cash Flow
Financing Cash FlowCr
1512-31117-7-1921
Net Cash Flow
Net Cash FlowCr
106-80-101
Free Cash Flow
Free Cash FlowCr
6-90-53-28419-21
CFO To PAT
CFO To PAT%
168.1142.8259.4-44.4129.2384.1181.8209.1
CFO To EBITDA
CFO To EBITDA%
86.457.3116.5-32.651.178.175.683.3

Ratios

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
16753150210157205327363487
Price To Earnings
Price To Earnings
9.35.211.08.313.722.616.220.937.6
Price To Sales
Price To Sales
0.40.20.60.60.50.70.91.11.5
Price To Book
Price To Book
1.60.51.21.40.91.21.71.72.2
EV To EBITDA
EV To EBITDA
5.94.16.78.38.89.89.110.517.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
18.924.029.525.827.831.837.238.638.6
OPM
OPM%
9.29.711.49.89.110.213.113.410.7
NPM
NPM%
4.73.95.17.23.62.15.45.33.2
ROCE
ROCE%
21.111.412.416.88.77.212.39.86.3
ROE
ROE%
16.88.810.516.66.83.69.58.34.8
ROA
ROA%
6.64.04.57.12.91.64.83.92.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
16753150210157205327363487
Price To Earnings
Price To Earnings
9.35.211.08.313.722.616.220.937.6
Price To Sales
Price To Sales
0.40.20.60.60.50.70.91.11.5
Price To Book
Price To Book
1.60.51.21.40.91.21.71.72.2
EV To EBITDA
EV To EBITDA
5.94.16.78.38.89.89.110.517.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
18.924.029.525.827.831.837.238.638.6
OPM
OPM%
9.29.711.49.89.110.213.113.410.7
NPM
NPM%
4.73.95.17.23.62.15.45.33.2
ROCE
ROCE%
21.111.412.416.88.77.212.39.86.3
ROE
ROE%
16.88.810.516.66.83.69.58.34.8
ROA
ROA%
6.64.04.57.12.91.64.83.92.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr795627515487257191163
Close PriceClose₹79.28179.3794.911,610.8058.679.8130.46
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE16.6211.1331.7437.596.7821.60
Price To SalesPS1.020.931.371.460.65109.520.28
RevenueRevenueCr7786763773343952583
Revenue Growth TTMRev Gr TTM%6.6%7.5%102.4%-1.0%-70.8%42.4%
PAT Growth TTMPAT Gr TTM%23.4%4.8%219.7%-44.7%81.7%35.8%
Market CapitalizationMkt CapCr795627515487257191163
Close PriceClose₹79.28179.3794.911,610.8058.679.8130.46
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE16.6211.1331.7437.596.7821.60
Price To SalesPS1.020.931.371.460.65109.520.28
RevenueRevenueCr7786763773343952583
Revenue Growth TTMRev Gr TTM%6.6%7.5%102.4%-1.0%-70.8%42.4%
PAT Growth TTMPAT Gr TTM%23.4%4.8%219.7%-44.7%81.7%35.8%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
ResultPPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
ResultPPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews